STD Preventable Vaccines
As science and medicine is advancing then we try to find a new way to prevent diseases through vaccines. To this date we have certain vaccines to prevent STD related diseases.
The FDA approved this vaccine, made by Merck for girls and women between the ages of 9 and 26, in order to help prevent cervical cancer. This vaccine is intended for prevention and not treatment for females in the above age range. This vaccine has not been approved for males. Please call for confirmation of availability prior to coming to our center. Again this vaccine is not for treatment and is only intended for prevention of (HPV) (types 6, 11, 16, 18) for female age 9-26 only.
Will HPV Vaccine help me if I already have HPV?
According to the vaccine insert: Yes, you may get a benefit from the vaccine
if you already have HPV. This is because many people are non infected with all 4 types of HPV which are contained in the vaccine.In clinical trials, individuals with current or past infections with one or more vaccine-related HPV types prior to vaccination were protected from diseases caused by the remaining vaccine HPV types. HPV Vaccine is not intended to be used for treatment for the above mentioned diseases. Talk to your health care professional for more information.
Hepatitis A is a viral infection of the liver caused by hepatitis A virus (HAV). HAV infection may be asymptomatic or its clinical manifestations may range in severity from a mild illness lasting 1-2 weeks to a severely disabling disease lasting several months. Clinical manifestations of hepatitis A often include fever, malaise, anorexia, nausea, and abdominal discomfort, followed within a few days by jaundice.
The first dose of hepatitis A vaccine could be administered and one month after receiving the first dose of monovalent hepatitis A vaccine, 94%-100% of adults and children will have protective concentrations of antibody. The final dose in the hepatitis A vaccine series is necessary to promote long-term protection. Many persons will have a detectable antibody to hepatitis A virus (anti-HAV) response to the monovalent vaccine by 2 weeks after the first vaccine dose
"If you are having sex, but not with one steady partner, use latex condoms correctly and every time you have sex. The efficacy of latex condoms in preventing infection with HBV is unknown, but their proper use may reduce transmission.
If you are pregnant, you should get a blood test for hepatitis B; Infants born to HBV-infected mothers should be given HBIG (hepatitis B immune globulin) and vaccine within 12 hours after birth. Do not shoot drugs; if you shoot drugs, stop and get into a treatment program; if you can't stop, never share drugs, needles, syringes, water, or "works", and get vaccinated against hepatitis A and B. Do not share personal care items that might have blood on them (razors, toothbrushes). Consider the risks if you are thinking about getting a tattoo or body piercing. You might get infected if the tools have someone else's blood on them or if the artist or piercer does not follow good health practices. If you have or had hepatitis B, do not donate blood, organs, or tissue. If you are a health care or public safety worker, get vaccinated against hepatitis B, and always follow routine barrier precautions and safely handle needles and other sharps. (View current post-exposure prophylaxis recommendations.)"
Herpes Vaccine Update
Herpes Vaccine Research Herpes Vaccine Study Movie
The vaccine has been invented and it seems to be in final phase of clinical trial. The vaccine could not give you herpes as it is not live.
"Herpevac trial for women" is to test the vaccine on uninfected female. The candidate would get tested before enrolling. The trial, co-sponsored by the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline Biological. Candidate to receive 3 doses of either vaccine in first 6 months and patient would be followed for 20 months. To this date there is no FDA approved Herpes vaccine to get marketed in the U.S. for public use. We make sure to be one of the first centers who give the vaccine as soon as it become available after possible FDA approval.